Unknown PHASE4 INTERVENTIONAL 2-arm NCT04197739

Fixed-dose Amikacin for Elderly UTI

Safety and Efficacy of Fixed-low-dose Amikacin for Urinary Tract Infection on the Elderly Patient

Sponsor: Rabin Medical Center

Conditions Elderly Infection Urinary Tract Infections

Interventions Amikacin

Updated 5 times since 2020 Last updated: Dec 12, 2019 Started: Dec 31, 2019 Primary completion: Dec 31, 2021 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Elderly Infection and Urinary Tract Infections, this trial is ongoing. The trial is conducted by Rabin Medical Center and has accumulated 5 data snapshots since 2019. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2022 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Jan 2022 [monthly]

Not Yet Recruiting PHASE4
Jan 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE4

First recorded

Dec 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rabin Medical Center

Data source: Rabin Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.